Close

Avalanche Biotechnologies (AAVL) Lifts Expected IPO Price

July 30, 2014 11:58 AM EDT Send to a Friend
Upcoming IPO Avalanche Biotechnologies (NASDAQ: AAVL) raised its expected IPO price from $13-$15 to $16-$17. The company still plans ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login